PURPOSE: The effects of stress-dose corticosteroid therapy were studied in a canine staphylococcal pneumonia model of septic shock. METHODS: Immediately following intrabronchial bacterial challenge, purpose-bred beagles were treated with stress doses of desoxycorticosterone (DOC), a mineralocorticoid agonist, and dexamethasone (DEX), a glucocorticoid agonist, or with placebo for 96 h. Oxacillin (30 mg/kg every 8 h) was started 4 h after infection onset. Bacterial dose was titrated to achieve 80-90 % lethality (n = 20) using an adaptive design; additional animals (n = 18) were investigated using the highest bacterial dose. RESULTS: Initial analysis of all animals (n = 38) demonstrated that the effects of DOC + DEX were significantly altered by bacterial dose (p = 0.04). The treatment effects of DOC + DEX were different in animals administered high or relatively lower bacterial doses in terms of survival (p = 0.05), shock reversal (p = 0.02), interleukin-6 levels (p = 0.02), and temperature (p = 0.01). DOC + DEX significantly improved the above parameters (p ≤ 0.03 for all) and lung injury scores (p = 0.02) after high-dose bacterial challenges, but not after lower challenges (p = not significant for all). Oxacillin trough levels were below the minimum inhibitory concentration of the infecting organism, and DOC + DEX increased the frequency of persistent staphylococcal bacteremia (odds ratio 3.09; 95 % confidence interval 1.05-9.11; p = 0.04). CONCLUSIONS: Stress-dose corticosteroids were only beneficial in cases of sepsis with high risk for death and even short courses may interfere with host mechanisms of bacterial clearance.
PURPOSE: The effects of stress-dose corticosteroid therapy were studied in a caninestaphylococcal pneumonia model of septic shock. METHODS: Immediately following intrabronchial bacterial challenge, purpose-bred beagles were treated with stress doses of desoxycorticosterone (DOC), a mineralocorticoid agonist, and dexamethasone (DEX), a glucocorticoid agonist, or with placebo for 96 h. Oxacillin (30 mg/kg every 8 h) was started 4 h after infection onset. Bacterial dose was titrated to achieve 80-90 % lethality (n = 20) using an adaptive design; additional animals (n = 18) were investigated using the highest bacterial dose. RESULTS: Initial analysis of all animals (n = 38) demonstrated that the effects of DOC + DEX were significantly altered by bacterial dose (p = 0.04). The treatment effects of DOC + DEX were different in animals administered high or relatively lower bacterial doses in terms of survival (p = 0.05), shock reversal (p = 0.02), interleukin-6 levels (p = 0.02), and temperature (p = 0.01). DOC + DEX significantly improved the above parameters (p ≤ 0.03 for all) and lung injury scores (p = 0.02) after high-dose bacterial challenges, but not after lower challenges (p = not significant for all). Oxacillin trough levels were below the minimum inhibitory concentration of the infecting organism, and DOC + DEX increased the frequency of persistent staphylococcal bacteremia (odds ratio 3.09; 95 % confidence interval 1.05-9.11; p = 0.04). CONCLUSIONS: Stress-dose corticosteroids were only beneficial in cases of sepsis with high risk for death and even short courses may interfere with host mechanisms of bacterial clearance.
Authors: Alexander R Novotny; Daniel Reim; Volker Assfalg; Felicitas Altmayr; Helmut M Friess; Klaus Emmanuel; Bernhard Holzmann Journal: Immunobiology Date: 2011-11-03 Impact factor: 3.144
Authors: Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson Journal: Crit Care Med Date: 2012-01 Impact factor: 7.598
Authors: Irene Cortés-Puch; Dong Wang; Junfeng Sun; Steven B Solomon; Kenneth E Remy; Melinda Fernandez; Jing Feng; Tamir Kanias; Landon Bellavia; Derek Sinchar; Andreas Perlegas; Michael A Solomon; Walter E Kelley; Mark A Popovsky; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson Journal: Blood Date: 2013-12-23 Impact factor: 22.113
Authors: Irene Cortés-Puch; Caitlin W Hicks; Junfeng Sun; Steven B Solomon; Peter Q Eichacker; Daniel A Sweeney; Lynnette K Nieman; Elizabeth M Whitley; Ellen N Behrend; Charles Natanson; Robert L Danner Journal: Am J Physiol Endocrinol Metab Date: 2014-10-07 Impact factor: 4.310
Authors: Dong Wang; Irene Cortés-Puch; Junfeng Sun; Steven B Solomon; Tamir Kanias; Kenneth E Remy; Jing Feng; Meghna Alimchandani; Martha Quezado; Christine Helms; Andreas Perlegas; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson Journal: Transfusion Date: 2014-03-03 Impact factor: 3.157
Authors: Ye Jin Park; Min Ji Lee; Jinkun Bae; Jung Ho Lee; Han A Reum Lee; Sehwan Mun; Yun-Seok Kim; Chang June Yune; Tae Nyoung Chung; Kyuseok Kim Journal: Life (Basel) Date: 2022-03-14